ACIU

AC Immune News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
AC Immune SA ACIU NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.04 -0.58% 6.87 00:00:00
Open Price Low Price High Price Close Price Prev Close
6.95 6.71 7.09 6.87 6.91
more quote information »

Recent News

Date Time Source Heading
3/23/202109:07EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/23/202109:02EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
3/23/202107:35SEEKAC Immune EPS misses by CHF0.02, misses on revenue; outlook
3/16/202108:22SEEKAC Immune shares rise on advancement of Alzheimer’s disease..
3/09/202108:04SEEKAC Immune presents new preclinical data in neurodegenerative..
2/26/202106:12EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/12/202117:23EDGARStatement of Ownership (sc 13g)
2/12/202111:00EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202108:22EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/22/202116:28EDGARStatement of Ownership (sc 13g)
1/14/202116:48EDGARAmended Statement of Ownership (sc 13g/a)
11/23/202016:31EDGARAmended Report of Foreign Issuer Pursuant to Rule 13a-16 or..
11/23/202006:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/18/202008:26EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/23/202017:24EDGARSecurities Registration (foreign Private Issuer) (f-3)
10/21/202006:42EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/23/202013:30DJNAC Immune Down 43%; Semorinemab Didn't Meet Endpoint in..
9/23/202009:23DJNAC Immune Down; Semorinemab Didn't Meet Efficacy Endpoint in..
9/23/202007:59DJNAC Immune: Semorinemab Didn't Meet Co-Primary Efficacy..
9/23/202007:56EDGARReport of Foreign Issuer (6-k)
9/08/202017:18EDGARReport of Foreign Issuer (6-k)
9/08/202017:07EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/05/202007:30EDGARReport of Foreign Issuer (6-k)
7/16/202008:30EDGARReport of Foreign Issuer (6-k)
6/26/202016:52EDGARReport of Foreign Issuer (6-k)
5/22/202008:40EDGARReport of Foreign Issuer (6-k)
5/04/202008:32EDGARReport of Foreign Issuer (6-k)
See more news about this stock »


Your Recent History
NASDAQ
ACIU
AC Immune
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.